Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

40%

4 of 10 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 3

1(12.5%)

8Total

N/A(7)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT05351775Not ApplicableCompleted

Low Workload Concept for the Detection of Silent Atrial Fibrillation (AF) and Atrial Fibrillation Burden in Patients At High Risk of AF and Stroke

Role: collaborator

NCT04223492Not ApplicableCompleted

Liquid Biopsies and Imaging in Breast Cancer

Role: collaborator

NCT05193760Completed

Robustness Check of Placement and Measurement Algorithms for Blood Flow Measurement on Common Carotid Artery

Role: collaborator

NCT04068740Completed

Personalised Decision Support for Heart Valve Disease

Role: collaborator

NCT02735187Not ApplicableCompleted

Efficacy and Safety of Blue Light (453 nm) Treatment for Mild Psoriasis Vulgaris Over Three Months Compared to Vitamin D.

Role: lead

NCT03085303Not ApplicableCompleted

Treatment of Atopic Dermatitis by a Full-Body Blue Light Device

Role: lead

NCT02004847Not ApplicableCompleted

Blue Light for Treating Psoriasis Vulgaris

Role: lead

NCT02002871Not ApplicableCompleted

Blue Light for Treating Eczema

Role: lead

NCT01528332Phase 3Completed

Blue Light Device for Pain Therapy

Role: lead

NCT01137266Not ApplicableCompleted

Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Disability in Patients With Osteoarthritis

Role: collaborator

All 10 trials loaded